Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer

Table 3

Correlation of CXC chemokine gene expression and clinical characteristics of patients with colon cancer in GSE41258.

Gene		Sex (female)	Group stage (III+IV)	T stage T3+T4	N stage (N1+N2)	M stage (yes)	P53 (mutant)
CXCL1			-0.252^0.001		-0.184^0.017	-0.252^0.001
CXCL2			-0.335^0.000		-0.283^0.000	-0.297^0.000
CXCL3			-0.280^0.000		-0.197^0.011	-0.269^0.000
CXCL4	-0.178^0.021	0.179^0.021
CXCL5
CXCL6
CXCL7
CXCL8	0.173^0.025						-0.189^0.032
CXCL9						-0.250^0.001
CXCL10						-0.221^0.004
CXCL11						-0.284^0.000	-0.204^0.020
CXCL12				0.171^0.027
CXCL13						-0.203^0.008
CXCL14							0.181^0.040

Correlation with value < 0.05; Correlation with value < 0.01.